VALEANT PHARMACEUTICALS DOWN TODAY THE MOTLEY FOOL SKIP CONTENT HELPING THE WORLD INVEST PREMIUM ADVICE HELP FOOL ANSWERS CONTACT LOGIN STOCK INVESTING PODCASTS GUIDES HOW TO RETIREMENT PERSONAL FINANCE MOTLEY FOOL OPTIONS TRADING FIND BROKER COMPARE EXCHANGE TRADED FUNDS COMMUNITY DISCUSSION BOARDS CAPS PROFILE WATCHLIST SCORECARD BOARDS REPORTS SETTINGS NONE SEARCH LONGTIME SHAREHOLDER BOARD MEMBER BILL ACKMAN GIVEN UP SOLD ENTIRE STAKE EMBATTLED TODD CAMPBELL DECISION INVESTOR MANAGER SELL SHARES STOCK PRICE SO WHAT MASSIVE WORTH ENDLESS STRING BAD NEWS CAUSED VALUE VALEANT DEPRESSED SUGGESTS LOSS INVESTMENT NORTH IMAGE GETTY IMAGES AS OF PERSHING SQUARE OWNED PLUS CALL OPTIONS SELLING UNEXPECTED ADVOCATE COMPANY INSTRUMENTAL SHAPE RESTRUCTURING REGAIN FOOTING PLANS ON LEAVING BOARD OF DIRECTORS AT THE END NOW WHAT CEO JOE PAPA EXPERIENCED VETERAN LEADING LITTLE EVIDENCE IMPROVING BUSINESS CONDITIONS RECENTLY REPORTED FINANCIAL RESULTS SHOWING SALES CONTINUE ASSETS WORK TO DO DEBT TOTALED NEARLY INTEREST EXPENSE TOTAL DATA SIZE COST LIABILITIES INTEREST COVERAGE RATIO MEASURE FLEXIBILITY CALCULATED EARNINGS BEFORE INTEREST DEPRECIATION REMAINS THE RATIO BELOW MINIMUM ABILITY DANGEROUSLY CLOSE DEFAULT MANAGEMENT TERMS LOWERED LAST GUIDANCE EBITDA BILLION MEANS MIGHT CHANGE SOMEWHAT ANNOUNCED OFFERING MONTH MATURITIES GIVE IT WIGGLE RISING INTEREST RATES PUSH UP POSITION STOCKS POSITIONS THE COMPANIES DISCLOSURE AUTHOR TODD BUY SIDE PORTFOLIO MANAGERS INDEPENDENT RESEARCHER CAPITAL RESEARCH FIRM ACTION ORIENTED IDEAS PROFESSIONAL INSIGHT VARIETY SMARTMONEY FOLLOW ARTICLE INFO HEALTH CARE READ IT HAPPENED CAUGHT PRICE HIKE THE LAUNDRY REASONS WHY VALEANT PHARMACEUTICALS INTL POSSIBLE SHOWS MANAGEMENT TEAM MISSING THE POINT RESOLUTIONS TURNAROUND FINALLY IN THE CARDS BROKERS TERMS OF USE PRIVACY POLICY POLICY PATENT INFORMATION TERMS AND CONDITIONS ALL RIGHTS RESERVED CURRENT
The World's Research Library